Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Protein Tyrosine Kinase (PTK) <strong>Inhibitor</strong>s, continued<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Phosphorylation/Dephosphorylation<br />
Product Cat. No. Comments Size Price<br />
TGF-b RI Kinase<br />
<strong>Inhibitor</strong><br />
N TGF-b RI Kinase<br />
<strong>Inhibitor</strong> II<br />
616451 {ALK5 <strong>Inhibitor</strong> I; [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole; TbR-I <strong>Inhibitor</strong>;<br />
Transforming Growth Factor-b Type I Receptor Kinase <strong>Inhibitor</strong>}<br />
A cell-permeable, potent, selective, ATP-competitive inhibitor of TGF-b type I receptor<br />
tyrosine kinase (IC 50 = 5 nM). Displays ~ 5-fold greater selectivity over p38a MAP<br />
kinase (IC 50 = 740 nM).<br />
616452 [ALK5 <strong>Inhibitor</strong> II; 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine;<br />
Transforming Growth Factor-b Type I Receptor Kinase <strong>Inhibitor</strong> II]<br />
A cell-permeable naphthyridinyl pyrazolo compound that acts as a potent, selective,<br />
and ATP-competitive inhibitor of TGF-b type I receptor (ALK5; IC 50 = 23 nM, 4 nM, and<br />
8 nM for ALK5 binding, ALK5 auto-phosphorylation and TGF-b cellular assay in HepG2<br />
cells, respectively). Minimally affects a panel of nine closely related kinases including<br />
p38 MAPK at IC 50 > 6 mM.<br />
2´-Thioadenosine 589400 (PD 157432)<br />
A potent, selective, and irreversible inhibitor of the ErbB subfamily of protein tyrosine<br />
kinases. Inactivates ErbB by modifying Cys 797 at the active site. Also inhibits ErbB2<br />
(IC 50 = 45 mM).<br />
(-)-Terreic Acid,<br />
Synthetic<br />
581810 {(1R,6S)-3-Hydroxy-4-methyl-7-oxabicyclo[4.1.0]hept-3-ene-2,5-dione}<br />
A cell-permeable, selective inhibitor of Bruton’s tyrosine kinase (BTK; IC 50 = 0 mM<br />
and 3 mM for the basal and activation levels), both in vitro and in vivo.<br />
N TrkA <strong>Inhibitor</strong> 648450 An oxindole compound that acts as a potent and highly selective inhibitor of TrkA<br />
(IC 50 = 6 nM), presumably by targeting the ATP-binding pocket of the kinase. Shown to<br />
exhibit ≥ 00-fold selectivity over c-fms, Cdk , Cdk2, Itk, JNK-3, p38, PDHK4, c-Raf ,<br />
Src, UL 3, and VEGFR2.<br />
TX- 23 655200 [2-((3,5-di-tert-Butyl-4-hydroxyphenyl)-methylene)-4-cyclopentene-1,3-dione]<br />
A cell-permeable inhibitor for Src, eEF2 kinase, and PKA (IC 50 = 2.2, 3.2, and 9.6 mM,<br />
respectively). Inhibits EGFR kinase and PKC only at much higher concentrations<br />
(IC 50 = 320 mM).<br />
N Tyrene CR4 655230 A cell-permeable hydroxystryrylacrylonitrile compound that potently inhibits the kinase<br />
activities of JAK2 and Bcr-Abl (IC 50 ~ 00–600 nM and 500–700 nM, respectively), and<br />
displays selectivity over other related kinases, namely, Btk, Lck, Lyn, Src, Syk, and<br />
ZAP-70 (IC 50 > 5 mM).<br />
Tyrosine-Specific<br />
Protein Kinase <strong>Inhibitor</strong><br />
VEGF Receptor Tyrosine<br />
Kinase <strong>Inhibitor</strong><br />
N VEGF Receptor Tyrosine<br />
Kinase <strong>Inhibitor</strong> II<br />
VEGF Receptor 2 Kinase<br />
<strong>Inhibitor</strong> I<br />
VEGF Receptor 2 Kinase<br />
<strong>Inhibitor</strong> II<br />
VEGF Receptor 2 Kinase<br />
<strong>Inhibitor</strong> III<br />
N InSolution VEGF<br />
Receptor 2 Kinase<br />
<strong>Inhibitor</strong> III<br />
657015 (p60 v-src 137-157 <strong>Inhibitor</strong> Peptide; VAPSDSIQAEEWYFGKITRRE)<br />
Inhibits p60 v-src (IC 50 = 7.5 mM) and epidermal growth factor receptor kinase.<br />
676475 {4-[(4´-Chloro-2´-fluoro)phenylamino]-6,7-dimethoxyquinazoline}<br />
A potent inhibitor of vascular endothelial growth factor (VEGF) receptor (Flt and KDR)<br />
tyrosine kinase activity (IC 50 = 2.0 mM and 00 nM for Flt and KDR, respectively).<br />
676481 {N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide}<br />
Shown to potently inhibit the kinase activities of KDR, Flt- , and c-Kit (IC 50 = 20 nM,<br />
80 nM, and 240 nM, respectively), and minimally inhibit c-Src and EGF-R activities<br />
(IC 50 = 7.0 mM and 7.3 mM). Further, inactive towards the inhibition of CDK- , c-Met,<br />
IGF- R, and PKA (IC 50 > 0 mM).<br />
676480 {(Z)-3-[(2,4-Dimethyl-3-(ethoxycarbonyl)pyrrol-5-yl)methylidenyl]indolin-2-one}<br />
A highly selective, cell-permeable indolin-2-one class of receptor tyrosine kinase<br />
inhibitor (IC 50 = 70 nM) for murine vascular endothelial growth factor receptor 2 (VEGF-<br />
R2; KDR/Flk- ). The inhibition is suggested to be competitive with respect to ATP.<br />
676485 [(Z)-5-Bromo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-1,3-dihydroindol-2-one]<br />
A cell-permeable receptor tyrosine kinase (RTK) inhibitor [IC 50 = 70 nM for VEGF-R2<br />
(KDR/Flk- ), 920 nM for PDGF-Rb, 4.92 mM for p60 c-src , and 3.3 mM for FGF-R ].<br />
The inhibition is suggested to be competitive with respect to ATP.<br />
676487 {3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one; SU5416}<br />
A cell-permeable, selective, ATP-competitive inhibitor of VEGF-R (KDR/Flk- ) and<br />
PDGFR kinases (IC 50 = mM and 20 mM, respectively in NIH-3T3 cells overexpressing<br />
Flk- ; K m = 530 nM for ATP).<br />
676498 A 0 mM (500 mg/2 0 ml) solution of VEGF Receptor 2 Kinase <strong>Inhibitor</strong> III<br />
(Cat. No. 676487) in DMSO.<br />
5 mg $ 05<br />
mg $98<br />
2 mg $ 29<br />
2 mg $ 03<br />
mg $ 00<br />
0 mg $90<br />
5 mg $82<br />
500 mg $204<br />
mg $85<br />
5 mg $ 29<br />
mg $99<br />
mg $99<br />
mg $ 8<br />
500 mg $73<br />
Technical Support<br />
Phone 800 628 8470<br />
E-mail calbiochem@emdbiosciences.com<br />
53